Product NDC: | 60681-1005 |
Proprietary Name: | Pleo Ex |
Non Proprietary Name: | candida albicans, candida parapsilosis and penicillium roqueforti |
Active Ingredient(s): | 5; 5; 5 [HP_X]/mL; [HP_X]/mL; [HP_X]/mL & nbsp; candida albicans, candida parapsilosis and penicillium roqueforti |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60681-1005 |
Labeler Name: | Sanum Kehlbeck GmbH & Co. KG |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED HOMEOPATHIC |
Start Marketing Date: | 19980119 |
Package NDC: | 60681-1005-2 |
Package Description: | 50 VIAL, GLASS in 1 CARTON (60681-1005-2) > 1 mL in 1 VIAL, GLASS |
NDC Code | 60681-1005-2 |
Proprietary Name | Pleo Ex |
Package Description | 50 VIAL, GLASS in 1 CARTON (60681-1005-2) > 1 mL in 1 VIAL, GLASS |
Product NDC | 60681-1005 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | candida albicans, candida parapsilosis and penicillium roqueforti |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 19980119 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Labeler Name | Sanum Kehlbeck GmbH & Co. KG |
Substance Name | CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; PENICILLIUM ROQUEFORTI |
Strength Number | 5; 5; 5 |
Strength Unit | [HP_X]/mL; [HP_X]/mL; [HP_X]/mL |
Pharmaceutical Classes |